Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00575497 · ClinicalTrials.gov registry record · NA

More Frequent Dialysis (>3 Treatments Per Week)

A NA study, sponsored by Satellite Healthcare.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT00575497: Completed NA study, sponsored by Satellite Healthcare.

NCT00575497 is a NA study that has completed, run by Satellite Healthcare. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00575497, a NA study, has completed, sponsored by Satellite Healthcare.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

The study compares the benefits of short daily hemodialysis six days a week, nocturnal (night time) hemodialysis six days a week, every other day and every other night hemodialysis to traditional three days a week hemodialysis.The hypothesis is that increasing hemodialysis treatment time and/or frequency will improve outcomes.

Interventions

  • PROCEDURE More frequent hemodialysis

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2005-01
Est. Completion 2012-08-07
Phase NA
Satellite Healthcare

18 total trials

What the finished NCT00575497 record still lists

NCT00575497 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which More frequent hemodialysis is the first listed.

NCT00575497 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00575497 about?

NCT00575497 is a clinical study titled "More Frequent Dialysis (>3 Treatments Per Week)". The study compares the benefits of short daily hemodialysis six days a week, nocturnal (night time) hemodialysis six days a week, every other day and every other night hemodialysis to traditional three days a week hemodialysis.The hypothesis is that increasing hemodialysis treatment time and/or freq...

What is the current status of trial NCT00575497?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2005-01. Estimated completion is 2012-08-07.

What interventions are being tested in trial NCT00575497?

The interventions under investigation include: More frequent hemodialysis (PROCEDURE).

Who is sponsoring clinical trial NCT00575497?

This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00575497's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00575497, the US trial registry maintained by the National Library of Medicine. NCT00575497 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.